Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
{{output}}
AKR1C3 is a drug target in hormonal and hormonal independent malignancies and acts as a major peripheral 17β-hydroxysteroid dehydrogenase to yield the potent androgens testosterone and dihydrotestosterone, and as a prostaglandin (PG) F synthase to produce pro... ...